Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.
about
Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitusAlternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitolEvaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetesMetabolomic profiling reveals severe skeletal muscle group-specific perturbations of metabolism in aged FBN ratsRacial differences in glycemic markers: a cross-sectional analysis of community-based dataLow levels of C-peptide have clinical significance for established Type 1 diabetes.Comparison of two assays for serum 1,5-anhydroglucitolNontraditional markers of glycemia: associations with microvascular conditions.Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1cSerum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.The roles of glycated albumin as intermediate glycation index and pathogenic protein.Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markersAlternative markers of hyperglycemia and risk of diabetes.Linagliptin increases incretin levels, lowers glucagon, and improves glycemic control in type 2 diabetes mellitus.Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes.Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes.Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.'Patient-centered care' for complex patients with type 2 diabetes mellitus-analysis of two cases.Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.Repeated 3-minute stair climbing-descending exercise after a meal over 2 weeks increases serum 1,5-anhydroglucitol levels in people with type 2 diabetes.Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes.A decrease in serum 1,5-anhydroglucitol levels is associated with the presence of a first-degree family history of diabetes in a Chinese population with normal glucose tolerance.The metabolism and transport of 1,5-anhydroglucitol in cells.Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus.The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis
P2860
Q26799252-F098AD15-E0F0-413D-8E20-D0C0519A3530Q26801852-76638195-57B2-4942-8728-3EE66E129B14Q33602114-FE4BFEA7-CC4D-4DA0-AC44-642DBB43E2D4Q33605921-A8652358-6749-42E7-B3EE-BAC457D39552Q33831561-FA8C10B4-28E7-4BE3-A6B7-BDBB892F732DQ34484912-39680744-B1CC-4286-A03B-18B7A88BADA5Q34594157-78108FF6-9B60-4728-961E-C06D1CD88FD8Q34718472-145C4B7B-D9DE-4F1F-8A81-0416087AEE52Q35056512-32413D30-4C41-480A-82D6-32CF7E52F5CFQ35101926-ED0786AE-8FD6-48DB-A69D-30547D16DD7BQ35688303-926192A6-9CE9-4E3F-87E6-D2715E64FF28Q35911117-D2586BC1-B6CC-4CDC-AC3B-3F9C62A3A186Q36194286-973F6401-B6B9-47B9-B30C-FCAF7A3AB4A0Q36234192-FED8CCEF-DB18-4A4B-9414-889E04776265Q36334628-3AEA6C2B-D261-4B18-8E88-08C87D35FF97Q36428096-67DB94D2-D198-4CA5-A25A-5EDB7D2C89CDQ36488560-2DAEA4C0-7FB5-4804-B9BE-E6FDF32F5E08Q36838473-B175EAE7-484A-4B06-BE96-3C0614756A49Q37007055-562AF8CC-3BE4-423F-A0A8-50B5012442ADQ37292095-C7872D7C-554A-4E9D-8119-12E06B0EB007Q37302392-2291BD09-E499-437D-A9C2-73EBCFBEB949Q37692779-0EAF1896-07A1-4FB9-ADD2-A56808B23F78Q38182542-A50AD56F-2ECE-4244-8424-FB5C2FEEA3E7Q39996202-A25596EF-D6AB-418B-8AAB-41D2ED6712F4Q40189389-D9D0E51E-014B-422C-A700-454094DCDBAFQ42322661-6B0157DA-4446-4E17-A84D-F4E53643CBEBQ43857832-B95F8291-7494-489A-9F95-DDCB4FDD1E23Q48150365-C439F166-23A0-4287-899E-7A7C8FCA9CB3Q48274733-793C0781-B2BC-40F5-B36C-B62FC3034FCEQ51272348-5545C127-AD72-401D-ADD0-24E2F74520D4Q51371829-AA8F999E-D97E-4CA3-A78A-5D0CFC4068B3Q57412755-79EC9237-F1A4-4486-9EA6-52A287C5B8B4
P2860
Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Association of 1,5-anhydrogluc ...... e in type 2 diabetic patients.
@ast
Association of 1,5-anhydrogluc ...... e in type 2 diabetic patients.
@en
type
label
Association of 1,5-anhydrogluc ...... e in type 2 diabetic patients.
@ast
Association of 1,5-anhydrogluc ...... e in type 2 diabetic patients.
@en
prefLabel
Association of 1,5-anhydrogluc ...... e in type 2 diabetic patients.
@ast
Association of 1,5-anhydrogluc ...... e in type 2 diabetic patients.
@en
P2093
P2860
P356
P1433
P1476
Association of 1,5-anhydrogluc ...... se in type 2 diabetic patients
@en
P2093
Christoph Stettler
Marcel Zwahlen
Matthias Stahl
Peter Diem
Sabin Allemann
Ulrich Keller
Walter Riesen
P2860
P304
P356
10.2337/DC08-0385
P407
P577
2008-04-21T00:00:00Z